ORASIS PHARMACEUTICALS

LIVE

Serial Number

88880329

Owner

Orasis Pharmaceuticals Ltd.

Attorney

B. Brett Heavner

Filing Date

Apr 21, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ORASIS PHARMACEUTICALS Trademark

Serial Number: 88880329 • Registration: 6458846

ORASIS PHARMACEUTICALS is a trademark filed by Orasis Pharmaceuticals Ltd. on April 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Orasis Pharmaceuticals Ltd.

6 Maskit st., P.O.B 12929
Herzliya 4673328 , IL

Entity Type: 99

Legal Representation

Attorney of Record

B. Brett Heavner

2,898 trademarks filed View all →

Correspondence Address

B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LL

901 NEW YORK AVENUE NW

WASHINGTON, DC 20001

UNITED STATES

Trademark Details

Filing Date

April 21, 2020

Registration Date

August 24, 2021

Published for Opposition

June 8, 2021

Goods & Services

Pharmaceutical preparations for treatment of eye disorders and diseases

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 24, 2026 REM1

REGISTERED-PRINCIPAL REGISTER

Aug 24, 2021 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 8, 2021 NPUB

PUBLISHED FOR OPPOSITION

Jun 8, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 19, 2021 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 6, 2021 CNSA

EXAMINER'S AMENDMENT ENTERED

May 6, 2021 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 6, 2021 GNEN

EXAMINERS AMENDMENT E-MAILED

May 6, 2021 GNEA

EXAMINERS AMENDMENT -WRITTEN

May 6, 2021 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 28, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 28, 2021 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Apr 23, 2021 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Mar 17, 2021 GNS3

LETTER OF SUSPENSION E-MAILED

Mar 17, 2021 GNSL

SUSPENSION LETTER WRITTEN

Mar 17, 2021 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 17, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 17, 2021 CRFA

ASSIGNED TO LIE

Mar 13, 2021 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 10, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 24, 2020 GNRN

NON-FINAL ACTION E-MAILED

Jul 24, 2020 GNRT

NON-FINAL ACTION WRITTEN

Jul 24, 2020 CNRT

ASSIGNED TO EXAMINER

Jul 14, 2020 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 30, 2020 NWOS

NEW APPLICATION ENTERED

Apr 24, 2020 NWAP

Related Trademarks

More from this Owner

EYEQ FORMULATION

QLOSI

More in Same Class